Recent studies have found that the upregulation of PIMREG expression is related to the poor prognosis of breast cancer, neuroblastoma, cholangiocarcinoma, osteosarcoma, glioma, prostate cancer and other cancers (9–14). Here, PIMREG is linked to cancer.